The pharmacokinetics of teicoplanin were studied following a 440 mg intravenous dose in six male volunteers. The levels of the compound were measured in serum, blister fluid and urine. The mean serum level 0-5 h after injection was 44-6 mg/1 falling to 3-6 mg/1 at 49 h. The elimination half-life of teicoplanin from serum was 34-2 h and the apparent distribution half-life 1-5 h. Penetration into blister fluid was moderately fast, the mean maximum concentration (14-8 mg/1) occurring at 2-7 h, and the mean percentage penetration being 77-4%. Urinary recovery of the drug was 48-3 % by 96 h
ABSTRACf: Teicoplanin is a new glycopeptideantibiotic with potent activityagainst gram-positivebacte...
Objective To investigate the basic pharmacodynamic properties of teicoplanin in vitro for Staphyloco...
ObjectiveTo study the elimination of teicoplanin during plasma exchange, a procedure currently used ...
We investigated the pharmacokinetic properties of teicoplanin, after 200 mg i.v. and i.m. administra...
Teicoplanin pharmacokinetics were evaluated after multiple-dose intravenous administration to health...
The pharmacokinetic profile of teicoplanin after single 3 mg/kg doses in adults with different degre...
International audienceObjectives: To investigate the population pharmacokinetics of teicoplanin in p...
Objective: To evaluate the pharmacokinetic appropriateness of a possible switch in dosing schedule f...
The nephrotoxicity and pharmacokinetics of teicoplanin were studied in an experimental rat model. Ne...
Teicoplanin is frequently administered to treat Gram-positive infections in pediatric patients. Howe...
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't. This trial has been registered in...
Teicoplanin (0-2 g) or vancomycin (1 g) were infused over 3 and 50 min respectively to six male volu...
teicoplanin in severely neutropenic patients. Population pharmacokinetic study o
Teicoplanin and vancomycin are antibiotics widely used in the therapy of bone and joint infections. ...
Teicoplanin is an antibiotic drug prescribed for the treatment of multidrug-resistant Gram-positive ...
ABSTRACf: Teicoplanin is a new glycopeptideantibiotic with potent activityagainst gram-positivebacte...
Objective To investigate the basic pharmacodynamic properties of teicoplanin in vitro for Staphyloco...
ObjectiveTo study the elimination of teicoplanin during plasma exchange, a procedure currently used ...
We investigated the pharmacokinetic properties of teicoplanin, after 200 mg i.v. and i.m. administra...
Teicoplanin pharmacokinetics were evaluated after multiple-dose intravenous administration to health...
The pharmacokinetic profile of teicoplanin after single 3 mg/kg doses in adults with different degre...
International audienceObjectives: To investigate the population pharmacokinetics of teicoplanin in p...
Objective: To evaluate the pharmacokinetic appropriateness of a possible switch in dosing schedule f...
The nephrotoxicity and pharmacokinetics of teicoplanin were studied in an experimental rat model. Ne...
Teicoplanin is frequently administered to treat Gram-positive infections in pediatric patients. Howe...
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't. This trial has been registered in...
Teicoplanin (0-2 g) or vancomycin (1 g) were infused over 3 and 50 min respectively to six male volu...
teicoplanin in severely neutropenic patients. Population pharmacokinetic study o
Teicoplanin and vancomycin are antibiotics widely used in the therapy of bone and joint infections. ...
Teicoplanin is an antibiotic drug prescribed for the treatment of multidrug-resistant Gram-positive ...
ABSTRACf: Teicoplanin is a new glycopeptideantibiotic with potent activityagainst gram-positivebacte...
Objective To investigate the basic pharmacodynamic properties of teicoplanin in vitro for Staphyloco...
ObjectiveTo study the elimination of teicoplanin during plasma exchange, a procedure currently used ...